Anis Davoudi1, Catherine Dion2, Shawna Amini2, Patrick J Tighe3, Catherine C Price2,4, David J Libon5, Parisa Rashidi1. 1. Department of Biomedical Engineering, University of Florida, Gainesville, FL, USA. 2. Clinical and Health Psychology, University of Florida, Gainesville, FL, USA. 3. Department of Psychology, Rowan University, Glassboro, NJ, USA. 4. Department of Anesthesiology, University of Florida, Gainesville, FL, USA. 5. Department of Geriatrics and Gerontology, New Jersey Institute for Successful Aging, School of Osteopathic Medicine, and the Department of Psychology, Rowan University, Glassboro, NJ, USA.
Abstract
BACKGROUND: Advantages of digital clock drawing metrics for dementia subtype classification needs examination. OBJECTIVE: To assess how well kinematic, time-based, and visuospatial features extracted from the digital Clock Drawing Test (dCDT) can classify a combined group of Alzheimer's disease/Vascular Dementia patients versus healthy controls (HC), and classify dementia patients with Alzheimer's disease (AD) versus vascular dementia (VaD). METHODS: Healthy, community-dwelling control participants (n = 175), patients diagnosed clinically with Alzheimer's disease (n = 29), and vascular dementia (n = 27) completed the dCDT to command and copy clock drawing conditions. Thirty-seven dCDT command and 37 copy dCDT features were extracted and used with Random Forest classification models. RESULTS: When HC participants were compared to participants with dementia, optimal area under the curve was achieved using models that combined both command and copy dCDT features (AUC = 91.52%). Similarly, when AD versus VaD participants were compared, optimal area under the curve was, achieved with models that combined both command and copy features (AUC = 76.94%). Subsequent follow-up analyses of a corpus of 10 variables of interest determined using a Gini Index found that groups could be dissociated based on kinematic, time-based, and visuospatial features. CONCLUSION: The dCDT is able to operationally define graphomotor output that cannot be measured using traditional paper and pencil test administration in older health controls and participants with dementia. These data suggest that kinematic, time-based, and visuospatial behavior obtained using the dCDT may provide additional neurocognitive biomarkers that may be able to identify and tract dementia syndromes.
BACKGROUND: Advantages of digital clock drawing metrics for dementia subtype classification needs examination. OBJECTIVE: To assess how well kinematic, time-based, and visuospatial features extracted from the digital Clock Drawing Test (dCDT) can classify a combined group of Alzheimer's disease/Vascular Dementiapatients versus healthy controls (HC), and classify dementiapatients with Alzheimer's disease (AD) versus vascular dementia (VaD). METHODS: Healthy, community-dwelling control participants (n = 175), patients diagnosed clinically with Alzheimer's disease (n = 29), and vascular dementia (n = 27) completed the dCDT to command and copy clock drawing conditions. Thirty-seven dCDT command and 37 copy dCDT features were extracted and used with Random Forest classification models. RESULTS: When HC participants were compared to participants with dementia, optimal area under the curve was achieved using models that combined both command and copy dCDT features (AUC = 91.52%). Similarly, when AD versus VaDparticipants were compared, optimal area under the curve was, achieved with models that combined both command and copy features (AUC = 76.94%). Subsequent follow-up analyses of a corpus of 10 variables of interest determined using a Gini Index found that groups could be dissociated based on kinematic, time-based, and visuospatial features. CONCLUSION: The dCDT is able to operationally define graphomotor output that cannot be measured using traditional paper and pencil test administration in older health controls and participants with dementia. These data suggest that kinematic, time-based, and visuospatial behavior obtained using the dCDT may provide additional neurocognitive biomarkers that may be able to identify and tract dementia syndromes.
Authors: Catherine C Price; Kelly Davis Garrett; Angela L Jefferson; Stephanie Cosentino; Jared J Tanner; Dana L Penney; Rodney Swenson; Tania Giovannetti; Brianne Magouirk Bettcher; David J Libon Journal: Clin Neuropsychol Date: 2009-08 Impact factor: 3.535
Authors: Loren P Hizel; Eric D Warner; Margaret E Wiggins; Jared J Tanner; Hari Parvataneni; Randall Davis; Dana L Penney; David J Libon; Patrick Tighe; Cynthia W Garvan; Catherine C Price Journal: Anesth Analg Date: 2019-07 Impact factor: 5.108
Authors: Mengtian Du; Stacy L Andersen; Stephanie Cosentino; Robert M Boudreau; Thomas T Perls; Paola Sebastiani Journal: Alzheimers Dement (Amst) Date: 2022-03-08
Authors: Yasunori Yamada; Kaoru Shinkawa; Masatomo Kobayashi; Varsha D Badal; Danielle Glorioso; Ellen E Lee; Rebecca Daly; Camille Nebeker; Elizabeth W Twamley; Colin Depp; Miyuki Nemoto; Kiyotaka Nemoto; Ho-Cheol Kim; Tetsuaki Arai; Dilip V Jeste Journal: JMIR Form Res Date: 2022-05-05